Toggle Offcanvas
...
 
Irbesartan Tenders

Irbesartan Tenders

View Irbesartan tenders, RFPs and contracts. Bid on readily available Irbesartan tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Irbesartan tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Irbesartan.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Irbesartan market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Irbesartan tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

27 Live Notices for Irbesartan Tenders

Showing 1 to 20

Prescription Service Drug Insurance Supplement Competition
country Saudi Arabia
posting date30 Jan 2025
deadline03 Nov 2025
Pharmaceutical Discount Agreements For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date12 Aug 2024
deadline03 Aug 2026
Medicines Containing The Active Ingredient Combination Irbesartan And Hydrochlorothiazide (Atc: C09Da24)
country Germany
posting date12 Aug 2024
deadline31 Jul 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Irbesartan And Hydrochlorothiazide (C09Da24) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date06 Aug 2024
deadline31 Jul 2026
Irbesartan Og Diuretica Tabletter Ba1.12.B
country Denmark
posting date27 Jan 2025
deadline01 Apr 2025
Irbesartan Tabletter Ba1.12.B
country Denmark
posting date27 Jan 2025
deadline01 Apr 2025
Irbesartan Og Diuretica Tabletter Ba1.12.B
country Denmark
posting date27 Dec 2024
deadline01 Apr 2025
Irbesartan Tabletter Ba1.12.B
country Denmark
posting date27 Dec 2024
deadline01 Apr 2025
Irbesartan Og Diuretica Tabletter Ba1.12.B
country Denmark
posting date26 Nov 2024
deadline01 Apr 2025
Irbesartan Tabletter Ba1.12.B
country Denmark
posting date26 Nov 2024
deadline01 Apr 2025
Irbesartan Og Diuretica Tabletter Ba1.12.B
country Denmark
posting date28 Oct 2024
deadline01 Apr 2025
Irbesartan Tabletter Ba1.12.B
country Denmark
posting date28 Oct 2024
deadline01 Apr 2025
Irbesartan Og Diuretica Tabletter Ba1.12.B
country Denmark
posting date26 Sep 2024
deadline01 Apr 2025
Irbesartan Tabletter Ba1.12.B
country Denmark
posting date26 Sep 2024
deadline01 Apr 2025
Irbesartan Og Diuretica Tabletter Ba1.12.B
country Denmark
posting date26 Aug 2024
deadline01 Apr 2025
Irbesartan Tabletter Ba1.12.B
country Denmark
posting date26 Aug 2024
deadline01 Apr 2025
Irbesartan Tabletter Ba1.12.B
country Denmark
posting date18 Jun 2024
deadline01 Apr 2025
Irbesartan Og Diuretica Tabletter Ba1.12.B
country Denmark
posting date18 Jun 2024
deadline01 Apr 2025
Irbesartan Og Diuretica Tabletter Ba1.12.B
country Denmark
posting date26 Jul 2024
deadline01 Apr 2025
Irbesartan Tabletter Ba1.12.B
country Denmark
posting date26 Jul 2024
deadline01 Apr 2025

Share Share this page